07:00 , Oct 23, 2006 |  BioCentury  |  Finance

Ebb & Flow

Nutraceuticals and OTC products are two areas where only a handful of VCs have historically played. But they may have a growing appeal as drugs become more expensive to develop and harder to reimburse. Indeed,...
02:59 , Jan 6, 2006 |  BC Extra  |  Financial News

XDx raises $26.5 million

Molecular diagnostic company XDx (South San Francisco, Calif.) raised $26.5 million in a series E round led by Duff, Ackerman & Goodrich. Other investors included Intel Capital; Kleiner Perkins Caufield & Byers; Texas Pacific Group;...
08:00 , Feb 14, 2005 |  BioCentury  |  Strategy

Prime real estate

The broad concept behind Five Prime Therapeutics Inc. - secreted protein discovery and development - is hardly new. But the company and its investors think Five Prime is the first to have a fully industrialized...